Paclitaxel, estramustine phosphate, and carboplatin in patients with advanced prostate cancer Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Combined Chemotherapy Protocols
  • Prostatic Neoplasms

abstract

  • TEC has significant antitumor activity and is well tolerated in patients with progressive androgen-independent prostate cancer.

publication date

  • January 2001

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed ID

  • 11134194

Additional Document Info

start page

  • 44

end page

  • 53

volume

  • 19

number

  • 1